Be the Change you want to see
We blaze the trail to that vision by offering a fully integrated universe of distinct cannabis-related brands, each fulfilling a different purpose. From Wholesale to D2C. From flowers to accessories. From medical use to lifestyle consumption. We cover and redefine the whole value chain not just because we can. But because it’s necessary to offer our customers and business partners a different experience in cannabis. With our profound product knowledge we lead the development of a versatile landscape of distinct, original strains. This is accompanied by a next-level digitalised experience, both through Europe’s leading telemedicine platform as well as an intuitive product shopping journey.
We empower people to move from patient to protagonist in the story of their own self-determined life. We’re neither just a business, nor a collection of brands. We’re trailblazers in a movement, ignited to reshape a whole industry.
Behind the Team
CEO, Co-Founder & Member of the Board
Niklas holds a masters degree in Management, is a serial entrepreneur, european medical cannabis pioneer and has been founding, investing in and building companies since 2017. His clear goal is to shape the future of the European Cannabis industry. He uses his deep expertise in the space, his entrepreneurial DNA and leadership skills to strategically grow the Bloomwell Group.
Chief Financial Officer
Tobias joined Bloomwell Group in 2021 and leads the finance department. Prior to joining the Company, he was part of the investment banking department of Alantra (M&A and Debt Advisory) and gained additional experience through his work in the corporate finance industry. Tobias holds a M.Sc. degree from the Napier University in Edinburgh, Scotland.
Co-Founder & CEO of Ilios Sante
Anna has multiple years of experience in the pharma industry as Manager and Entrepreneur. Her expertise lies in product procurement, the handling of Rx-pharmaceuticals and the efficient scalability of business models in high regulated markets. She holds a Master of Science double degree in the field of Management.
Dr. Julian Wichmann, M.D.
Co-Founder & CEO of Algea Care
Julian is a board-certified radiologist with an international research track record and gained digital health expertise at startups as well as on corporate level. His focus lies on advancing healthcare by providing an ideal digital patient journey considering the regulatory aspects of telemedicine with narcotic prescriptions.
CEO of Breezy
Janett joined Bloomwell Group in 2022 and leads the Breezy business. Prior to joining Bloomwell, Janett built and led several B2C as well as B2B brands and teams in the Fast Moving Consumer Goods sector as well as accompanied the transformation of traditional business units into the digital age. She brings a proven track record of adapting brands and products to rapidly changing market conditions.
Co-Founder & Member of the Board
Samuel is Vice President in the Investment Banking group at Berenberg. Samuel’s advisory experience includes mergers, acquisitions as well as capital market transactions such as IPOs. Samuel brings deep expertise in the Online/Tech space having advised on numerous transactions for VC-backed, sponsor-backed, early-stage, family-owned and public companies. Samuel holds a M.Sc. degree from the University of Mannheim, Germany.
Prof. Dr. Reinhard Meier
Member of the board
Reinhard has studied Medicine and business administration in Munich, Nice, France and San Francisco, USA. He is working as director of radiology at a large hospital group. He was Co-founder of TeleClinic, leading health platform in Germany. Partner at Soleria Capital, a Venture Capital Firm. Seed Investor of several startups.
Member of the board
Boris Jordan is an American businessman with a long and distinguished history in frontier markets and industries. He is the Founding Partner of Measure 8 Venture Partners, as well as Executive Chairman of Curaleaf Holdings, a publicly traded global cannabis company.
Member of the board
William Muecke is the co-founder and managing member of Artemis Growth Partners, a private equity fund focused 100% on cannabis investing. Will is a former managing director in the investment banking division at Goldman, Sachs & Co. and is an expert in corporate finance, merger advisory, and private equity investing. Will brings over 30 years of experience in global finance, in board governance, and in impact (ESG) investing to the company.
Measure 8 Venture Partners is a venture capital and hedge fund firm launched by Boris Jordan in 2018 to capitalize on the emergence of the U.S. and global cannabis industry.
M4 Capital is focused on venture capital investments in the ideas and leaders of tomorrow. We are passionate about companies that boost efficiency and transparency, make lives easier and healthier, and enable constant change for the better.
Voxel Ventures is an early-stage Micro VC in Frankfurt/DE, investing globally into promising digital health startups. It just takes one voxel to change the world.
Artemis Growth Partners is a team of professional investors, operators, and advisors who have built and run successful, award-winning domestic and international ESG and impact funds.
LA Finance – Change the world. Supporting change, having invested in a.o. signature products, dynamic eflow, EFARM.
Moritz Bleibtreu is one of the most important German actors since the 1990s. With investing into Bloomwell he is following his great interest for the developments surrounding cannabis as a medical and recreational drug.
German Cannabis Business Industry Association e.V.
The voice of the cannabis industry in Germany, representing all industry segments and company sizes in political institutions and administrations. Bundling political, technological, and economic expertise in order to advocate for favorable political framework conditions.
How to get involved
Are you interested in joining the green revolution? Please feel free to contact us at:
Or click the link below to be taken to our contact section.